Literature DB >> 8492224

Establishment and characterization of a new human clear-cell sarcoma cell-line, HS-MM.

H Sonobe1, M Furihata, J Iwata, Y Ohtsuki, H Mizobuchi, H Yamamoto, O Kumano.   

Abstract

We have established and morphologically characterized a new human clear-cell sarcoma cell-line, HS-MM, from the pleural effusion of a 39-year-old man with pulmonary metastasis derived from the primary popliteal tumour. The HS-MM cells were round or spindle-shaped, with round nuclei containing extremely prominent nucleoli. Light microscopically, the heterotransplanted nude mouse tumours showed essentially the same features as those of the original sarcoma, revealing an alveolar pattern of tumour cells with abundant clear cytoplasm. Both in vitro and in vivo, the cells reacted with anti-S-100 protein and melanoma-specific HMB 45 antibodies by immunohistochemistry. Ultrastructurally, the cells contained round euchromatin-rich nuclei with large nucleoli revealing conspicuous nucleolonema, and a large amount of glycogen and a few lysosomal dense bodies, but no premelanosomes in their cytoplasm. The HS-MM cell line was thus fully proven to exhibit the unique characteristics of a clear sarcoma both in vitro and in vivo, being also compatible with an amelanotic melanoma. This cell line will therefore be extremely useful for clinicopathological and histogenetic studies on clear cell sarcomas.

Entities:  

Mesh:

Year:  1993        PMID: 8492224     DOI: 10.1002/path.1711690307

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  7 in total

1.  Explant culture of sarcoma patients' tissue.

Authors:  Roman Muff; Sander M Botter; Knut Husmann; Joelle Tchinda; Philomina Selvam; Franziska Seeli-Maduz; Bruno Fuchs
Journal:  Lab Invest       Date:  2016-04-25       Impact factor: 5.662

2.  Establishment and proteomic characterization of patient-derived clear cell sarcoma xenografts and cell lines.

Authors:  Marimu Sakumoto; Rieko Oyama; Mami Takahashi; Yoko Takai; Fusako Kito; Kumiko Shiozawa; Zhiwei Qiao; Makoto Endo; Akihiko Yoshida; Akira Kawai; Tadashi Kondo
Journal:  In Vitro Cell Dev Biol Anim       Date:  2017-12-01       Impact factor: 2.416

3.  Therapeutic potential of CPI-613 for targeting tumorous mitochondrial energy metabolism and inhibiting autophagy in clear cell sarcoma.

Authors:  Yuki Egawa; Chiemi Saigo; Yusuke Kito; Toshiaki Moriki; Tamotsu Takeuchi
Journal:  PLoS One       Date:  2018-06-07       Impact factor: 3.240

4.  CD151 confers metastatic potential to clear cell sarcoma of the soft tissue in animal model.

Authors:  Keisuke Kawashima; Chiemi Saigo; Yusuke Kito; Yuki Hanamatsu; Yuki Egawa; Tamotsu Takeuchi
Journal:  Oncol Lett       Date:  2019-03-19       Impact factor: 2.967

5.  An obstructive role of NK cells on metastatic growth of clear-cell sarcoma cells in a xenoplant murine model.

Authors:  Yuki Hanamatsu; Chiemi Saigo; Yusuke Kito; Tamotsu Takeuchi
Journal:  Mol Clin Oncol       Date:  2020-11-12

6.  The melanocyte inducing factor MITF is stably expressed in cell lines from human clear cell sarcoma.

Authors:  K K C Li; J Goodall; C R Goding; S-K Liao; C-H Wang; Y-C Lin; H Hiraga; T Nojima; K Nagashima; K-L Schaefer; K A W Lee
Journal:  Br J Cancer       Date:  2003-09-15       Impact factor: 7.640

7.  Establishment of a novel clear cell sarcoma cell line (Hewga-CCS), and investigation of the antitumor effects of pazopanib on Hewga-CCS.

Authors:  Hidetatsu Outani; Takaaki Tanaka; Toru Wakamatsu; Yoshinori Imura; Kenichiro Hamada; Nobuhito Araki; Kazuyuki Itoh; Hideki Yoshikawa; Norifumi Naka
Journal:  BMC Cancer       Date:  2014-06-19       Impact factor: 4.430

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.